1. Home
  2. >Research
  3. >Underestimated Risk Of Secondary Complications In Pathogenic And Glucose Elevating Gck Variant Carriers With Type 2 Diabetes
Skip to main content
Research

Underestimated risk of secondary complications in pathogenic and glucose-elevating GCK variant carriers with type 2 diabetes

November 21, 2024Published Research

Ready to see the whole picture?

Connect with our team to discover how Helix can transform your approach to genomic medicine.

Connect with us
Underestimated risk of secondary complications in pathogenic and glucose-elevating GCK variant carriers with type 2 diabetes | Helix